Intravenous immunoglobulin treatment stabilizing a patient with Anti-PL7 antisynthetase syndrome with interstitial lung disease and eosinophilic inflammation

Antisynthetase syndrome (AS) is a rare autoimmune disease characterized by autoantibodies against aminoacyl-transfer RNA synthetase and clinical features which can include interstitial lung disease (ILD). Current available evidence of treatment is based on expert opinions and case reports. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Peshbahar, Soran, Hyldgaard, Charlotte, Bendstrup, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256658/
https://www.ncbi.nlm.nih.gov/pubmed/35814032
http://dx.doi.org/10.1016/j.rmcr.2022.101686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256658/
https://www.ncbi.nlm.nih.gov/pubmed/35814032
http://dx.doi.org/10.1016/j.rmcr.2022.101686

Ejemplares similares